Browse articles from EyeWorld.org related to presbyopia. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA clearance for viscodelivery system
➤ FDA approves IND application for immunomodulatory agent for dry eye
➤ Phase 2b results for sustained-release, IOP-lowering implant
➤ Positive topline Phase 2 results for investigational dry eye drug
➤ Phase 2 trials begin for two transdermal drug formulations
➤ Second pivotal trial begins for wet AMD gene therapy
➤ Alcon completes acquisition of Ivantis
➤ ASCRS news and events
➤ Study: Possible therapy to avoid visual problems induced by space travel
➤ Exploratory study finds investigational eye drop for dry eye safe and tolerable
➤ New drug candidate in development to treat dry eye and ocular pain
➤ Results from year 2 of Phase 3 trial of brolucizumab for DME
➤ ASCRS news and events
➤ Positive topline clinical data for investigational topical presbyopia treatment
➤ FDA grants IDE for modular IOL with fluid-filled optic
➤ First participants enrolled in Phase 3 trial for mydriasis reversal
➤ Analysis: Subgroup of dry eye patients benefit from investigational treatment
➤ NDA approved for generic drug designed to treat inflammation, pain
➤ First patient enrolled in Phase 2a study for wet AMD and DME candidate
➤ ASCRS news and events
➤ State of the union on laser vision correction ➤ Practical insights on MIGS ➤ Glaucoma pipeline therapies and alternative therapeutics ➤ Future of refractive cataract surgery ➤ American Glaucoma Society Subspecialty Day Lecture ➤ Presbyopia correction with refractive IOLs
➤ Enrollment begins in Phase 3 pilocarpine study for presbyopia
➤ New digital platform enhances connectivity among clinic-to-OR technologies
➤ Positive results from Phase 1 safety study of investigational compound for AMD, DME
➤ Alcon to acquire Ivantis
➤ ASCRS news and events
➤ FDA approves first prescription eye drop for presbyopia treatment
➤ Primary endpoint reached in Phase 2 trial for dry eye disease drug
➤ New type of retinal nerve cell discovered
➤ Companies enter collaboration to develop an oral DME, wet AMD treatment
➤ iCare USA acquires remote patient-monitoring tech company
➤ ASCRS news and events
➤ Survey: Patient perspectives on presbyopia
➤ Study: Wearable visual field testing device correlates with standard testing, offers efficiency
➤ Endpoints not met in blepharitis drug trial
➤ Retinal cell protection observed in non-clinical model with investigational IOP-lowering drug
➤ Extension study of investigational wet AMD therapy shows reduction of injection burden
➤ 12-month safety data reported from Phase 3 bevacizumab trial
➤ ASCRS news and events
Dr. Waring implants a hybrid diffractive extended depth of focus and multifocal toric IOL during a refractive lens exchange.
Source: George Waring IV, MD, FACS
The large number of patients worldwide with presbyopia creates a unique opportunity for eyecare providers to improve patients’ quality of life, according to George Waring IV, MD, FACS. He and Shamik Bafna, MD, discussed some of the surgical and pharmacological options.
Dr. Williamson implants the first Synergy in Louisiana.
Source: Blake Williamson, MD
This “YES connect” column examined trifocal, combined multifocal-EDOF, and accommodating technology on the horizon with input from three experts.
Both the ASCRS Annual Meeting and the ASOA Annual Meeting began on Saturday, with opening sessions and a variety of symposia, courses, labs, and other sessions.
